Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

April 06, 2015; 84 (14 Supplement) April 23, 2015

Greater Consumption of Coffee is Associated with Reduced Odds of Multiple Sclerosis (S45.004)

Ellen Mowry, Anna Hedstrom, Milena Gianfrancesco, Xiaorong Shao, Catherine Schaefer, Lisa Barcellos, Tomas Olsson, Lars Alfredsson
First published April 8, 2015,
Ellen Mowry
1Johns Hopkins University Baltimore MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Hedstrom
4Karolinska Institutet Stockholm Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Milena Gianfrancesco
5University of California, Berkeley Berkeley CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaorong Shao
5University of California, Berkeley Berkeley CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine Schaefer
2Kaiser Permanente Division of Research Oakland CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa Barcellos
5University of California, Berkeley Berkeley CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomas Olsson
3Karolinska Institutet Solna Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lars Alfredsson
4Karolinska Institutet Stockholm Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Citation
Greater Consumption of Coffee is Associated with Reduced Odds of Multiple Sclerosis (S45.004)
Ellen Mowry, Anna Hedstrom, Milena Gianfrancesco, Xiaorong Shao, Catherine Schaefer, Lisa Barcellos, Tomas Olsson, Lars Alfredsson
Neurology Apr 2015, 84 (14 Supplement) S45.004;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
0

Share

  • Article
  • Info & Disclosures
Loading

Abstract

OBJECTIVE: We sought to determine if coffee consumption is associated with MS risk. BACKGROUND: Previous studies on caffeine consumption and MS risk have been inconclusive. Caffeine intake has been associated with reduced odds of Parkinson’s and Alzheimer’s diseases and thus may be neuroprotective. DESIGN/METHODS: Using two population-based case-control studies (a Swedish study of 1,629 incident cases and 2,807 controls, and a Kaiser Permanente Northern California (United States) study of 584 prevalent cases and 581 controls), the association of coffee consumption prior to disease onset with the odds of MS was evaluated in multivariate unconditional logistic regression models, adjusted for potential confounding factors, including (but not limited to) age, sex, smoking, body mass index, and sun exposure habits. RESULTS: In the Swedish cohort, coffee consumption was associated with reduced odds of MS compared to subjects who reported no coffee consumption. Consuming at least 6 cups of coffee daily during the index year was associated with an adjusted odds ratio (OR) for MS of 0.67 (95[percnt] CI 0.47-0.95). The corresponding ORs for those who reported high coffee consumption 5 or 10 years before the index year were 0.70 (95[percnt] CI 0.50-0.99) and 0.72 (95[percnt] CI 0.48-1.06). In the Kaiser Permanente Northern California study, among those who consumed 4 our more cups of coffee daily prior to the index year, the OR for MS was also 0.67 (95[percnt] CI 0.47-0.95). CONCLUSIONS: High coffee consumption is associated with reduced odds of MS. Caffeine has neuroprotective properties and seems to suppress the production of proinflammatory cytokines, which may be mechanisms that explain the observed association. Study Supported by: Swedish Medical Research Council; Swedish Research Council for Health, Working Life and Welfare; Knut and Alice Wallenberg, AFA, and Swedish Brain Foundations; Swedish Association for Persons with Neurological Disabilities; NIH/NINDS R01 NS049510; R01 NS0495103; NIH/NIAID R01 A1076544

Disclosure: Dr. Mowry has received research support from Teva Neuroscience. Dr. Hedstrom has nothing to disclose. Dr. Gianfrancesco has nothing to disclose. Dr. Shao has nothing to disclose. Dr. Schaefer has nothing to disclose. Dr. Barcellos has nothing to disclose. Dr. Olsson has received personal compensation for activities with Biogen Idec. Dr. Alfredsson has nothing to disclose.

Thursday, April 23 2015, 1:00 pm-2:45 pm

  • Copyright © 2015 by AAN Enterprises, Inc.

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 99 (5)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise